Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer

Koutras, A., Mastronikolis, N., Evans, T., Papadeas, E., Makatsoris, T. and Kalofonos, H. (2008) Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer. Acta Oncologica, 47(6), pp. 1171-1173. (doi: 10.1080/02841860802213328)

Full text not currently available from Enlighten.


Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Evans, Professor Jeff
Authors: Koutras, A., Mastronikolis, N., Evans, T., Papadeas, E., Makatsoris, T., and Kalofonos, H.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Acta Oncologica
ISSN:0284-186X

University Staff: Request a correction | Enlighten Editors: Update this record